A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (VICTORIA)
Purpose
The purpose of this research study is to determine the safety and effectiveness of an experimental study drug (MK-1242) for the treatment of heart failure.
Procedures
- Visit with your doctor about 12 times throughout the study (1.5 - 3.5 years)
- Take study medication as directed
- Visits may include: blood samples, a physical exam, and optional heart imaging procedures
Eligibility
- Heart failure
For additional eligibility criteria please contact the study team.
Age
18 and under
18 to 65
Gender
Male
Female
Monetary compensation
Yes
Can be done from home
No
Keywords
Heart failure - overview, Coronary heart disease, CardiomyopathyPrincipal Investigator
Juan Vilaro, MDDepartment
Division of Cardiology
Contact Information
Begin a new search for other research studies
Studies listed on this site have been approved by a UF Institutional Review Board (IRB), which works to ensure the welfare and rights of research participants as required by federal regulations. Study listings are provided by the UF Clinical and Translational Science Institute in collaboration with UF research teams and the UF IRBs.